Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.
about
Coming of age: the artificial pancreas for type 1 diabetesProgress of artificial pancreas devices towards clinical use: the first outpatient studiesContinuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.Multinational Home Use of Closed-Loop Control Is Safe and Effective.Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness FactorMulticenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.AP@home: The Artificial Pancreas Is Now at HomeAssessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.Artificial Pancreas Project at Cambridge 2013Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.Technology to Reduce Hypoglycemia.The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitusAccuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.Home Use of an Artificial Beta Cell in Type 1 DiabetesMetabolic Control With the Bio-inspired Artificial Pancreas in Adults With Type 1 Diabetes: A 24-Hour Randomized Controlled Crossover Study.Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trialCombining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreasDay-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.A review of personalized blood glucose prediction strategies for T1DM patients.Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach.Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel sDevelopment of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring.Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against Hypoglycemia.12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery.Type 1 Diabetes - A Clinical Perspective.Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.Bolusing frequency and amount impacts glucose control during hybrid closed-loop.Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
P2860
Q26745886-232F5981-A0FE-46B0-B108-7560595C4445Q26825236-73CCFA40-9807-43AC-9690-9C902AADBF53Q28071439-392E5410-0F5A-45E0-A4DC-5D7E5DF71370Q30276768-25D369C9-3D40-43C8-8845-AF06D0FF39EDQ30278964-162E91A4-7835-4498-9021-89DD819286CCQ30279078-B24CA1E1-A47A-4892-B8E0-0C9C49428AE9Q30300933-7D1B77FA-6335-4739-BD47-4E1A941861C4Q30354088-7F1AB41F-D89C-4E7A-B5FD-57E60C2ED380Q34151693-6EB9DA26-5A93-4DF6-B801-A942AE9AA5BDQ35858586-86E4F2F9-0CC8-4D0A-8689-A81DFD9B3EC9Q35877744-70A860E1-0C2B-4AC3-885B-52BEBF4739E4Q35918438-6FCDF78E-6927-4074-A6BE-1497BB482651Q36159119-9D832C01-75E4-4A2B-9F00-0C6A82757297Q36291620-9B2AF156-06F1-48B2-A33C-9CDCA8E959ACQ36419734-1A54A308-9D5E-4E66-BB6B-E7666BCB6D7DQ36638921-009B118B-2899-46BC-AC3C-74C26D2C27A2Q36705282-4DC46949-DED2-462B-BA82-7093C5AB47EBQ36800053-B7449B53-5CE3-484B-86B2-DFFCAA99FAF5Q36815738-7225E9A8-DA89-46E1-AB71-80A97AF607CBQ37025568-76DDCD52-298A-41E5-AC08-38D2733377A7Q37288511-ED97BA38-6661-4189-9D02-3EFB7D229B5AQ37288539-C628C61F-DF68-42B3-9B40-CADC341714A5Q37736558-9DF3940E-11A7-4D24-B6BE-0303684E0044Q38498029-9CFB5980-8CFE-4E71-8340-C55231ABBE09Q38824570-40E70C46-1741-4017-90FB-4C60BFAEEE80Q38958529-922B65A5-A92A-430D-AB88-BD44D4050CC6Q39071115-A2CF2003-1C10-416C-8E26-A565224A5332Q39306224-CF3AD1C3-FE3E-43BA-990D-E4A070D6AEAAQ39436182-864A1B4E-C390-4E37-9528-112A7E69C2D6Q41196110-1EE4A56D-8D93-42CF-8E09-5C93D933E9A9Q41692670-12832868-7E15-4C5A-ADA2-2C3046E9B0D6Q42696179-E729C1A2-B1E0-449C-A85A-BE7D8B5F6F32Q42718199-D23F9B5D-D1D8-448E-A669-5D6D2ED120D4Q43208434-9056E1A2-1FD8-4E03-B844-7A26391C2AB7Q47638746-872BAEF1-C9B7-4276-8DE0-4BB24F5C1B15Q47778034-E6BB83DD-963D-43A4-A5DA-DFAEECDCEB14Q48326082-356286E2-162F-4F62-83F3-3093517325A9Q48347087-F881AFA5-BEE5-4405-B37D-88972DE168F0Q48640080-40433D67-DDF9-4789-85DF-04745E2B343EQ50643784-A64A64EB-6B95-449B-9999-62EFC21E6E3B
P2860
Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Day and night home closed-loop ...... er randomized crossover study.
@en
Day and night home closed-loop ...... er randomized crossover study.
@nl
type
label
Day and night home closed-loop ...... er randomized crossover study.
@en
Day and night home closed-loop ...... er randomized crossover study.
@nl
prefLabel
Day and night home closed-loop ...... er randomized crossover study.
@en
Day and night home closed-loop ...... er randomized crossover study.
@nl
P2093
P50
P356
P1433
P1476
Day and night home closed-loop ...... er randomized crossover study.
@en
P2093
AP@home Consortium
Carsten Benesch
Harald Kojzar
Hood Thabit
Janet M Allen
Julia K Mader
Lalantha Leelarathna
Lucy Michalewski
Malgorzata E Wilinska
Marianna Nodale
P304
P356
10.2337/DC13-2911
P407
P577
2014-07-01T00:00:00Z